Related Experiment Video
Updated: Aug 25, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Risk stratification in patients with hypertrophic cardiomyopathy: Looking beyond the left side myocardial function
Hao-Chih Chang1,2, Hao-Min Cheng3,4,5,6, Ling Kuo2,5,7
1Department of Medicine, Taipei Veterans General Hospital Yuanshan and Suao Branch, Yilan, Taiwan, ROC.
Insights
Right ventricular (RV) function, measured by tricuspid annular plane systolic excursion (TAPSE) and RV free wall strain, predicts cardiac events in hypertrophic cardiomyopathy (HCM) patients. This highlights the importance of assessing RV function for improved risk stratification.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Cardiac Electrophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by heterogeneous patient outcomes.
- Current risk stratification primarily focuses on left ventricular (LV) function.
- The prognostic significance of right ventricular (RV) function in HCM remains under-investigated.
Purpose of the Study:
- To investigate the prognostic value of right ventricular (RV) function in patients with hypertrophic cardiomyopathy (HCM).
- To determine if RV functional parameters improve risk stratification beyond traditional LV measures.
Main Methods:
- Retrospective cohort study of 56 HCM patients.
- Assessment of conventional parameters (LVEF, TAPSE) and RV free wall strain via speckle tracking.
- Primary endpoint: composite of heart failure hospitalization, sustained ventricular tachycardia, or all-cause death.
Main Results:
- RV free wall strain and TAPSE were impaired in patients with cardiovascular events.
- TAPSE and RV free wall strain were independent predictors of adverse outcomes after adjusting for LVEF.
- Incorporating RV parameters (TAPSE or RV free wall strain) significantly improved risk reclassification compared to LV strain alone.
Conclusions:
- Right ventricular (RV) function, assessed by TAPSE or RV free wall strain, is a significant predictor of cardiac events in HCM.
- Comprehensive evaluation of RV function is valuable for enhancing risk stratification in HCM patients.
Background:
Patients with hypertrophic cardiomyopathy (HCM) have heterogeneous outcomes. As risk stratification mostly focuses on left-side myocardial function, we sought to investigate the prognostic value of right ventricular (RV) function in patients with HCM.
Methods:
This retrospective cohort study included patients with HCM. Conventional ventricular functional parameters, including left ventricular ejection fraction (LVEF), tricuspid annular plane systolic excursion (TAPSE), and fractional area change were obtained. The longitudinal strain was analyzed using the speckle tracking method. The primary endpoint was defined as a composite of hospitalization for heart failure, sustained ventricular tachycardia, or all-cause death.
Results:
A total of 56 patients with HCM (aged 58.0 ± 14.9 years, 64.3% male) were included. After a mean follow-up duration of 30.1 ± 17.4 months, primary endpoints developed in 10 (20%) of 50 patients who were treated medically. Patients with cardiovascular events had a more reduced LV thickest segmental strain, worse TAPSE, and more impaired RV free wall strain. After adjusting for age, sex, and LVEF, TAPSE (hazard ratio [HR], 95% confidence intervals [CIs]: 0.24, 0.06-0.93) and RV free wall strain (HR, 95% CIs:1.12, 1.03-1.21) remained independent prognostic predictors. Incorporating either TAPSE or RV free wall strain provides incremental prognostic value to the LV strain alone (net reclassification improvement by 31.4% and 34.1%, respectively, both p < 0.05).
Conclusion:
RV function assessed by TAPSE or RV free wall strain is predictive of subsequent cardiac events, suggesting that a comprehensive evaluation of RV function is useful for risk stratification in patients with HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction

